What Wegovy actually costs in 2026.

The list price, explained

Novo Nordisk sets the wholesale acquisition cost (WAC) for Wegovy at approximately $1,349 per monthly package. WAC is the price pharmacies pay Novo Nordisk, before any rebates or discounts. The retail price you see at the pharmacy counter is usually WAC plus a modest pharmacy markup. It is the same across all five dose strengths (0.25, 0.5, 1.0, 1.7, and 2.4 mg), which is unusual — most medications are priced by strength.

In 2025, Novo Nordisk launched a major pricing change: a direct-to-consumer self-pay program through NovoCare Pharmacy that bypasses the traditional insurance and pharmacy-benefit-manager (PBM) system entirely. The self-pay price is $499 per month for any dose. You pay Novo Nordisk directly and the medication ships from a mail-order pharmacy.

This was a direct response to competition from Eli Lilly\'s Zepbound (tirzepatide), which had launched its own LillyDirect self-pay program in 2024, and to political pressure on drug prices. For uninsured patients or people whose insurance excludes weight loss medications, it was a meaningful reduction — roughly 63% off retail.

Wegovy price by source

Source: Novo Nordisk list price, NovoCare Pharmacy, GoodRx average, verified Apr 2026.

Wegovy price comparison by pharmacy

For patients who use insurance, your out-of-pocket cost depends mainly on your plan — pharmacy-to-pharmacy differences are usually small. For cash-pay patients who want to use a local pharmacy instead of NovoCare, here are typical retail cash prices (not including coupons) as of early 2026:

For most people, the NovoCare direct-to-consumer option is the cheapest route without insurance. The only reason to choose a retail pharmacy at the higher cash price is if you need same-day pickup or want to keep all your prescriptions at one location.

Wegovy cost with insurance

Coverage varies enormously. Many commercial insurance plans now cover Wegovy, but they typically place it on Tier 3 (non-preferred brand) and require prior authorization. Common prior authorization criteria include:

• BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity
• Documented weight loss attempts (usually 6 months of diet and exercise)
• Prescribed by a physician (not always a specialist)
• No contraindications (thyroid cancer history, MEN 2, pregnancy)

If your plan covers Wegovy, your monthly copay is usually between $25 and $100 before any additional savings. Apply the NovoCare Savings Card and many patients pay $0 to $25 per month for up to 12 months.

For detailed coverage information by insurer, see our Wegovy insurance guide. If your plan denies coverage, see our savings and coupons guide for alternatives.

Medicare and Medicaid

Medicare

Medicare Part D is prohibited by statute (the Medicare Modernization Act of 2003) from covering drugs prescribed solely for weight loss. For most of Wegovy\'s existence, this meant Medicare beneficiaries could not get it covered.

That changed in March 2024 when the FDA approved Wegovy for a new indication — reducing the risk of major adverse cardiovascular events (MACE) in adults with obesity and established cardiovascular disease. Following the approval, CMS clarified that Part D plans are permitted (though not required) to cover Wegovy when prescribed for the cardiovascular indication. Coverage for weight loss alone remains excluded.

Whether your specific Part D plan covers it depends on the plan. Check the plan\'s formulary for "semaglutide (Wegovy)" and look for prior authorization requirements related to the cardiovascular indication.

Medicaid

Medicaid coverage for Wegovy varies dramatically by state. As of early 2026, approximately 13 states cover GLP-1 medications for obesity treatment through Medicaid, including Massachusetts, California (partial), Pennsylvania, and Delaware. The majority of states still exclude obesity medications from Medicaid coverage. Check your state\'s Medicaid preferred drug list or call your state Medicaid agency.

Tricare

Tricare generally does not cover Wegovy for weight loss. It covers semaglutide for diabetes (Ozempic) when medically indicated. Discuss alternatives with your military health provider.

Seven ways to reduce what you pay

1. Use NovoCare self-pay ($499/month) if you have no insurance or your plan excludes Wegovy.
2. Apply the NovoCare Savings Card if you have commercial insurance that covers Wegovy — drops copays to $0-$25.
3. Request prior authorization appeal if your insurance denies the first time. Most denials are reversed after an appeal with complete documentation.
4. Ask about step therapy — some plans require you to try Saxenda or another medication first. If you have, document it.
5. Telehealth bundled pricing — some online providers offer flat monthly rates that include the prescription, consult, and medication.
6. Check HSA/FSA eligibility — Wegovy is an eligible expense with a Letter of Medical Necessity from your provider, reducing the effective cost by your marginal tax rate.
7. Do not use "compounded semaglutide" from non-licensed sources. The FDA has warned repeatedly about potency, purity, and sterility issues.

Wegovy cost vs alternatives

For more head-to-head cost and efficacy comparisons, see Wegovy vs Zepbound and Wegovy vs Ozempic.

Frequently Asked Questions

How much does Wegovy cost per month?

The retail list price of Wegovy is approximately $1,349 per month for all five doses (0.25, 0.5, 1.0, 1.7, and 2.4 mg). Through NovoCare Pharmacy, Novo Nordisk offers a self-pay cash price of $499 per month for uninsured patients. With commercial insurance and the NovoCare Savings Card, eligible patients may pay as little as $0 to $25 per month.

How much is Wegovy without insurance?

Without insurance, your cheapest legitimate option is the NovoCare Pharmacy direct-to-consumer self-pay program at $499 per month. At retail pharmacies without insurance, cash price typically runs $1,200 to $1,450 per month depending on the pharmacy and any GoodRx-style coupons. Telehealth platforms that bundle the prescription with a brief consult can also offer package pricing.

Does the price of Wegovy change by dose?

No. Novo Nordisk charges the same price for every Wegovy dose strength — whether you are on the starting 0.25 mg dose or the maintenance 2.4 mg dose, the monthly list price and NovoCare self-pay price are identical. This is intentional: it removes the financial incentive to delay dose escalation and makes it easier to budget over a long course of treatment.

Is Wegovy cheaper at Costco?

Costco pharmacy typically has one of the lower cash prices for Wegovy among retail chains — often $50 to $100 less per month than CVS or Walgreens. You do not need a Costco membership to use the pharmacy by federal law in most states. However, even Costco cash price (typically $1,280-$1,380) is still much higher than the NovoCare direct self-pay price of $499.

Why is Wegovy so expensive in the US?

Wegovy is much more expensive in the US than in other developed countries for several reasons: the US does not directly negotiate drug prices with Medicare (until recently), the patient assistance system is fragmented, and Novo Nordisk has a patent-protected monopoly on semaglutide until at least 2031-2033. In Europe, the same medication typically costs $200-$350 per month. The 2025 launch of the $499 NovoCare direct price was Novo Nordisk's response to pricing pressure and competition from tirzepatide (Zepbound).

Is there a generic Wegovy?

No. As of 2026, there is no FDA-approved generic version of Wegovy. Semaglutide is protected by patents held by Novo Nordisk that are expected to begin expiring around 2031-2033 in the US. Some compounding pharmacies have offered "compounded semaglutide" during FDA-declared shortage periods, but these are not FDA-approved, are not therapeutically equivalent to Wegovy, and carry additional risks around purity, potency, and sterility. The FDA has repeatedly warned against their use.

How much does Wegovy cost with insurance?

If your commercial insurance plan covers Wegovy, your out-of-pocket cost depends on your plan's copay or coinsurance tier. Wegovy is typically placed on Tier 3 (non-preferred brand), which carries copays of $50 to $100 per month without further discounts. When you combine insurance coverage with the NovoCare Savings Card, copays drop to $0 to $25 per month for most eligible patients. If your plan does not cover Wegovy, you pay the full retail price unless you use the NovoCare self-pay program.

Is Wegovy covered by Medicare?

By statute, Medicare Part D is not permitted to cover drugs prescribed solely for weight loss. However, in March 2024 the FDA approved Wegovy for reduction of major adverse cardiovascular events in adults with obesity and established cardiovascular disease. Following that approval, CMS announced in early 2024 that Part D plans are permitted (though not required) to cover Wegovy when prescribed for the cardiovascular indication. Coverage for the weight loss indication alone remains excluded.